EXTON, Pa.--(BUSINESS WIRE)--Nicholas C. Nicolaides, Ph.D., president and chief executive officer of Morphotek, Inc., a U.S. subsidiary of Eisai Co., Ltd., was awarded the Ernst & Young Entrepreneur Of The Year® for his innovations and contributions to the life science industry in the Greater Philadelphia Region. Dr. Nicolaides was honored for his development of a whole genome evolution technology called morphogenics, which became the basis for Morphotek, a biopharmaceutical company focused on the discovery and development of therapeutic monoclonal antibodies.
